Why participation in an international clinical trial platform matters during a pandemic? Launching REMAP-CAP in Japan

Kazuhiro Kamata, Kazuaki Jindai, Nao Ichihara, Hiroki Saito, Hideaki Kato, Hiroyuki Kunishima, Ayumi Shintani, Osamu Nishida, Shigeki Fujitani

Research output: Contribution to journalLetterpeer-review

Fingerprint

Dive into the research topics of 'Why participation in an international clinical trial platform matters during a pandemic? Launching REMAP-CAP in Japan'. Together they form a unique fingerprint.

Medicine & Life Sciences